Crossmark

0Phobia – towards a virtual cure for acrophobia: study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2704-6

Published Online: 2018-08-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Donker, T.

Van Esveld, S.

Fischer, N.

Van Straten, A.
Funding

Funding for this research was provided by:

Stichting voor de Technische Wetenschappen (2016/STW/00099738)

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NL) (314-98-076)
License Information

Text and Data Mining valid from 2018-08-09
More Information

Article History

Received: 13 July 2017

Accepted: 24 May 2018

First Online: 9 August 2018

Ethics approval and consent to participate

: This study has received ethical approval by the Medical Ethics Committee of the VU University Medical Center (registration number 2016-563). Only participants who consent to participate in the trial will be included in the study. A copy of the consent form can be requested by contacting the corresponding author.

: TD is married to the founder of InSession, the private company that, in collaboration with the Vrije Universiteit, developed the VR application 0Phobia used in the present study and which is intended for release on the open market. Hence, TD will not be involved in data analysis or any decisions related to the publication of findings. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.